Gossypetin Alleviates DSS-induced Colitis by Regulating COX2 and ROS-JNK Signaling
Gossypetin shows therapeutic potential for mitigating the symptoms and progression of colitis by targeting ROS-JNK signaling involved in inflammation and tissue damage. This highlights the potential of natural compounds such as gossypetin for targeted therapies with reduced side effects and improved efficacy.
Authors
- Kanghyun Park
- Lei Ma (ORCID: https://orcid.org/0000-0002-3011-8080)
- Zae Young Ryoo
- C.-W. Kim
- Soyoung Jang (ORCID: https://orcid.org/0000-0003-2673-4259)
- Ke Huang (ORCID: https://orcid.org/0000-0002-9355-7224)
- Hyeonjin Kim (ORCID: https://orcid.org/0000-0001-9054-3874)
- Dong Joon Kim (ORCID: https://orcid.org/0000-0002-5792-1500)
- Zhibin Liu (ORCID: https://orcid.org/0000-0003-2053-5136)
- Eungyung Kim
- Myoung Ok Kim
- Jun Koo Yi (ORCID: https://orcid.org/0000-0002-9954-2779)
- Yonghun Sung
Institutions
- Hankyong National University (KR)
- Kyungpook National University (KR)
- China-US (Henan) Hormel Cancer Institute (CN)
- National Institute of Animal Science (KR)
- Daegu-Gyeongbuk Medical Innovation Foundation (KR)
Publication Details
- Journal
- Current Pharmaceutical Biotechnology
- Published
- 2024-11-27
- DOI
- https://doi.org/10.2174/0113892010331882240901095733
- Citations
- 1
- Primary Topic
- Pharmacological Effects of Natural Compounds
- Type
- article
- Field-Weighted Citation Impact
- 0.47